Epitope-specific immunotherapy induces immune deviation of proinflammatory T cells in rheumatoid arthritis
about
Regulation of adaptive immunity; the role of interleukin-10FOXP3 ensembles in T-cell regulationTransforming growth factor-beta-induced regulatory T cells referee inflammatory and autoimmune diseases.T cell epitope immunotherapy induces a CD4+ T cell population with regulatory activityRole of regulatory T cells in experimental arthritis and implications for clinical use.Antigen-based immunotherapy for autoimmune disease: current statusSkewed Helper T-Cell Responses to IL-12 Family Cytokines Produced by Antigen-Presenting Cells and the Genetic Background in Behcet's DiseaseHeat shock protein bystander antigens for peptide immunotherapy in autoimmune diseaseVaccine against autoimmune disease: antigen-specific immunotherapyActive suppression induced by repetitive self-epitopes protects against EAE developmentTolerization against atherosclerosis using heat shock protein 60Preventing autoimmune arthritis using antigen-specific immature dendritic cells: a novel tolerogenic vaccineAlarmins: awaiting a clinical responseModulation of T cell function by combination of epitope specific and low dose anticytokine therapy controls autoimmune arthritis.Biological heterogeneity of the peptide-binding motif of the 70-kDa heat shock protein by surface plasmon resonance analysis.IL-10 is critically involved in mycobacterial HSP70 induced suppression of proteoglycan-induced arthritis.Heat shock protein-derived T-cell epitopes contribute to autoimmune inflammation in pediatric Crohn's disease.T cell recognition of naturally presented epitopes of self-heat shock protein 70.Hsp70 expression and induction as a readout for detection of immune modulatory components in food.De novo generation of antigen-specific CD4+CD25+ regulatory T cells from human CD4+CD25- cells.Cord blood CD4+ T cells respond to self heat shock protein 60 (HSP60)Antigen-specific immunotherapy for type 1 diabetes: maximizing the potential.Increased CD45RA+ FoxP3(low) regulatory T cells with impaired suppressive function in patients with systemic lupus erythematosus.Peptides presented by HLA-DR molecules in synovia of patients with rheumatoid arthritis or antibiotic-refractory Lyme arthritisIn Vivo Induction of Functionally Suppressive Induced Regulatory T Cells from CD4+CD25- T Cells Using an Hsp70 Peptide.Genetic deletion of a single immunodominant T-cell response confers susceptibility to virus-induced demyelination.T cells in the control of organ-specific autoimmunityTregs and allergic diseaseExogenous tumour necrosis factor alpha induces suppression of autoimmune arthritisThe involvement of heat-shock proteins in the pathogenesis of autoimmune arthritis: a critical appraisal.Heat-shock proteins induce T-cell regulation of chronic inflammation.Peptide-based therapeutic vaccines for allergic and autoimmune diseases.IL-10 is essential for disease protection following intranasal peptide administration in the C57BL/6 model of EAET regulatory cells in allergen-specific immunotherapy.Peptide-based immunotherapy: a novel strategy for allergic disease.Definition of target antigens for naturally occurring CD4(+) CD25(+) regulatory T cellsRecognition of self-heat shock protein 60 by T cells from patients with atopic dermatitisRegulatory T cells in human disease and their potential for therapeutic manipulation.Translating the concept of suppressor/regulatory T cells to clinical applications.Heat-shock protein 60 as a tool for novel therapeutic strategies that target the induction of regulatory T cells in human arthritis.
P2860
Q21131215-1664B6D3-A5C6-4B3A-AA48-D55B806DC1F3Q24299602-DC81FE36-A8EF-412A-AD3E-1B5947DDDA48Q24804340-27C0813B-1AEE-48C9-84E1-1EF0F43D796BQ24805470-EE130EC3-D8AF-498A-8126-D075A5E92AFFQ24816917-816F5BFB-408B-485E-95E4-4CF6A15AF0BFQ26852915-6541CEF4-8A81-411D-8FE2-383A874F3F19Q26866098-AD7F09DD-44D5-4242-B1A1-52AA112F31A1Q27008837-CADC50A8-EAE5-4013-B489-04663B2F81F6Q27028121-DAA45E75-D4CE-4258-99EC-612E382EF45DQ27318065-ADF3BE52-B6A1-4846-AA33-533BA7D3ED76Q28081051-42F9996A-D293-46AE-B6FD-6A7954E247EAQ28200149-DA7128DB-9701-4440-B2F3-89322D9B5D08Q30523797-7216B307-FC0B-411B-851D-2A96C5F514CCQ33267344-8B263443-32D8-4430-BFEF-44904AC9EA1EQ33290603-F5CCDDAA-6989-4214-9946-EC156E0759A8Q33399722-063C04EC-2783-4A77-A891-B5713E248E5EQ33514815-D1E3AC44-AE51-4925-BACC-22CB07C6FB79Q33700807-21FAC019-8C71-410F-A965-DFF910111EADQ33838876-0E60227B-1D28-4691-A567-08121EAB9BB5Q33932462-5B24752E-C4A3-4D91-B4F8-ED6732EDB001Q34023284-BE6CC214-4C8B-48DD-A3A8-F7B8BE6966DCQ34082782-C0988835-2002-4707-9CDD-83ADE0CE13C3Q34233668-FA211F56-48EB-45C8-BC13-28072022538AQ34616781-FC3CBF77-F5C7-4F89-8300-34D1C07B098FQ35673344-E3E13006-31B8-4748-8431-858C477432C5Q35768390-6F01991C-5BE2-4F3B-8C03-F3B9ACD6FFDCQ35836118-E1900A86-1061-43F8-A488-4F861AB596DFQ35951537-79BD7758-9023-4E12-BB0F-26D2C517B8BFQ36067286-C59750BA-39FD-4334-934E-203E501ACD2BQ36079214-16736ABD-DE99-4A73-A59F-BC9A3C1B3738Q36085622-6122F2FE-AD31-4CB3-841A-CCB824CBE97AQ36090197-B7E4EF5B-3EDE-4DC7-AC97-B4A7976E3F99Q36103132-ECD16B41-2E96-48C4-BC00-72956C4A2303Q36327399-A87F960B-2C9D-43FC-80DC-97BD491AFE0AQ36350581-D661D05C-537C-4139-A33B-2270F0100EAFQ36402710-044C78E0-A733-484D-BD4B-F7DF95256797Q36428129-372B0B20-CD61-45CE-A12E-2CB455B2F835Q36455974-B938EA61-AB62-407E-8070-47A2C03F520CQ36466223-946C4EAD-B458-44E8-8BC9-DF575F950770Q36480993-D2EE7414-D90A-475A-8D94-41E5659F2F29
P2860
Epitope-specific immunotherapy induces immune deviation of proinflammatory T cells in rheumatoid arthritis
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 March 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Epitope-specific immunotherapy ...... cells in rheumatoid arthritis
@en
Epitope-specific immunotherapy ...... cells in rheumatoid arthritis.
@nl
type
label
Epitope-specific immunotherapy ...... cells in rheumatoid arthritis
@en
Epitope-specific immunotherapy ...... cells in rheumatoid arthritis.
@nl
prefLabel
Epitope-specific immunotherapy ...... cells in rheumatoid arthritis
@en
Epitope-specific immunotherapy ...... cells in rheumatoid arthritis.
@nl
P2093
P2860
P356
P1476
Epitope-specific immunotherapy ...... cells in rheumatoid arthritis
@en
P2093
Berent J Prakken
Charles Berry
Diane Amox
Dustan Bonnin
Francesca Giannoni
Gisella Puga Yung
Isme de Kleer
John Scavulli
Paola Lanza
Rodrigo Samodal
P2860
P304
P356
10.1073/PNAS.0400061101
P407
P577
2004-03-15T00:00:00Z